Risk warning
Draft pending legal review. This is not the final version.
Please read this warning before investing in Fusion. Investing in a property development is not the same as putting money in a bank.
Main risks
- Your capital is at risk. If the development fails, you may lose everything you invest.
- No deposit guarantee or compensation scheme. Your investment is not covered by deposit guarantee schemes (Directive 2014/49/EU) or by any investor compensation scheme (Directive 97/9/EC).
- Returns are not guaranteed. We don’t promise any return. Any figure in the information sheet is an estimate, not a commitment.
- Illiquid investment. You are unlikely to get your money back before the project ends. There is no organised market that guarantees a buyer or a price.
- Construction risk. Permit delays, cost overruns, technical problems or a contractor’s insolvency can extend the term or reduce the outcome.
- Market risk. House prices may fall between the start of construction and the sale.
- Project company risk. The company developing Fusion may fail to meet its obligations or become insolvent.
- Technology risk. The register of holdings is kept on the Sui blockchain. An error in that register or in the network could delay the recording of your holding.
Spread your risk
Only invest money you can afford to lose, and don’t put your savings into a single project. If you are a non-sophisticated investor, the platform will ask you to simulate your ability to bear losses, calculated as 10% of your net worth, and will warn you if an investment exceeds €1,000 or 5% of that net worth.
Reflection period
If you are a non-sophisticated investor, you have 4 calendar days from making an investment offer to withdraw it without giving a reason or paying a penalty.
Who makes the offer
This site belongs to the project company and only gives information about the project. It is not a crowdfunding platform and does not accept investments or funds. The offer will be made only through [Plataforma autorizada], a crowdfunding service provider authorised by Spain’s securities regulator, the CNMV (no. [____]), under Regulation (EU) 2020/1503. The offer is not directed at US persons.
The Spanish version prevails in case of discrepancy.